SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-22-024871
Filing Date
2022-09-01
Accepted
2022-09-01 17:53:31
Documents
10

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 731603
2 ex1-2.htm EX-1.2 246637
3 ex1-3.htm EX-1.3 12478
4 ex4-1.htm EX-4.1 770186
5 ex4-2.htm EX-4.2 809000
6 ex5-1.htm EX-5.1 35564
7 ex23-1.htm EX-23.1 5641
8 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 108183
9 forms-3_001.jpg GRAPHIC 5932
10 ex5-1_001.jpg GRAPHIC 3359
  Complete submission text file 0001493152-22-024871.txt   2733409
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267236 | Film No.: 221222591
SIC: 2834 Pharmaceutical Preparations